Stock Analysis
- Brazil
- /
- Paper and Forestry Products
- /
- BOVESPA:DXCO3
Dexco First Quarter 2024 Earnings: Misses Expectations
Dexco (BVMF:DXCO3) First Quarter 2024 Results
Key Financial Results
- Revenue: R$1.94b (up 13% from 1Q 2023).
- Net loss: R$35.1m (down by 124% from R$147.7m profit in 1Q 2023).
- R$0.043 loss per share (down from R$0.18 profit in 1Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Dexco Revenues and Earnings Miss Expectations
Revenue missed analyst estimates by 2.6%. Earnings per share (EPS) was also behind analyst expectations.
Looking ahead, revenue is forecast to grow 5.0% p.a. on average during the next 3 years, compared to a 6.5% growth forecast for the Global Forestry industry.
Performance of the market in Brazil.
The company's shares are down 4.9% from a week ago.
Risk Analysis
We should say that we've discovered 4 warning signs for Dexco (1 makes us a bit uncomfortable!) that you should be aware of before investing here.
Valuation is complex, but we're helping make it simple.
Find out whether Dexco is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.
View the Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About BOVESPA:DXCO3
Fair value with limited growth.